PE-backed manufacturer

Capital should not be deployed merely because it is available

A premium manufacturer with €25m to deploy and four years to an exit.

An illustrative scenario. It does not describe a client or a real company.

Frame

Objective, horizon, non-negotiables and who holds authority.

A PE-backed premium manufacturer has €25 million available for one major investment. The fund expects an exit within four years.

Management prefers organic investment. The board likes the acquisition because it changes the equity story immediately.

The three uses of the capital

Acquire a smaller competitor for immediate market share and US distribution. The valuation is high, customer concentration is material and the business remains dependent on its founder.
Invest organically in production modernisation, two new products and a US commercial team. Returns take longer and the market window may narrow.
Reduce debt, strengthen the balance sheet and wait for a better opportunity.

Which option creates transferable, defensible value within the ownership horizon, and which merely produces the appearance of action?

Objective: Create value that a buyer will pay for at exit, and that does not leave with any one person.
Horizon: Four years to exit.
Non-negotiables: Covenants are not put at risk to fund an equity story.
No commitment is made on evidence that does not yet exist.
Who decides: Board and investment committee. Management recommends. Commitment of the capital is not management’s decision.

Observe

What is established, what is assumed and what is missing.

Every item is typed. Facts come from the scenario. Assumptions are illustrative quantities added so the consequences can be calculated. Unknowns are left unknown.

Established 4

Fact:
€25m is available for one major investment. The fund expects an exit within 4 years.
Given in the scenario. High confidence.
Fact:
The target brings market share and US distribution. Its valuation is high, customer concentration is material and it depends on its founder.
Given in the scenario. High confidence.
Fact:
The organic plan is production modernisation, 2 new products and a US commercial team. Returns take longer and the market window may narrow.
Given in the scenario. High confidence.
Fact:
Management prefers organic investment. The board prefers the acquisition.
Given in the scenario. High confidence.

Assumed 5

Assumption:
EBITDA of €18m, net debt of €60m at 8.5%, a leverage covenant of 4x and an exit multiple of 9x.
Illustrative modelling assumption. Medium confidence.
Assumption:
The target earns €3.6m EBITDA and is priced at €25m, with €2m of integration cost. 45% of its revenue rests on the founder’s relationships. Its top 3 customers are 55% of revenue.
Illustrative modelling assumption. Low confidence.
Assumption:
Untested, 50% of founder-dependent revenue is assumed to leave with the founder. If transfer is demonstrated, 10%. If it is not transferable, 80%.
Illustrative modelling assumption. Low confidence.
Assumption:
The organic plan adds €4.5m EBITDA at maturity after 3 years. Without differentiation it achieves 30% of that.
Illustrative modelling assumption. Low confidence.
Assumption:
Customer-level diligence on transferability takes about 90 days.
Illustrative modelling assumption. Medium confidence.

Not yet known 4

Unknown:
Whether the target’s customer relationships transfer once the founder leaves.
Given in the scenario. Low confidence.
Unknown:
Whether there is unmet demand, and a durable reason the new products can win.
Given in the scenario. Low confidence.
Unknown:
The depth and independence of the target’s management team.
Given in the scenario. Low confidence.
Unknown:
Whether the organisation can execute the organic plan, and how quickly it reaches value.
Given in the scenario. Low confidence.

Model

The relationships that can be calculated, and their limits.

Only relationships that can honestly be calculated are modelled. Apply one bounded pressure, or move one assumption, and follow the consequence across the organisation.

Apply one pressure

As briefedThe scenario as it was first described. The board sets a deadlineThe board asks for the capital to be committed within 60 days.A rival bidder appearsCompetition for the target takes the price to €29m.Trading softens and rates riseEBITDA slips to €16m and the cost of debt rises to 10.5%.

Or change one assumption: Target revenue resting on the founder

45%

Bounded to 15% to 75%.

What changed

First effects

Second effects

Third effects

Fourth effects

Thresholds

Finance

Leverage3.3x

Headline price multiple6.9x

Interest saved by paying down debt€8.5m

Leverage after paydown1.9x

Covenant headroom0.7x

Effective price multiple9.7x

Acquisition value, on retained earnings−€1.9m

On retained earnings the acquisition loses valueCrossed

Covenant headroom is thinNot crossed

Commercial

Founder-dependent revenue lost50%

Organic value, if the products win€15.5m

Organic value, if they do not−€12.9m

Target earnings at risk€0.8m

Target earnings retained€2.8m

Transferability is not demonstratedCrossed

Differentiation is not evidencedCrossed

Governance

Acquisition value, as presented€7.4m

Days by which the deadline precedes the evidence0 days

The deadline arrives before the evidenceNot crossed

Risk

Customer concentration is materialCrossed

Apply a pressure to see what moves, in what order, and where it stops.

Contest

Functional positions, conflict and a critic.

Each function answers in the same structure: a recommendation, the evidence it rests on, the assumption underneath, its confidence, the consequence for another function and the authority it would need.

Governance

Argues for: acquire the competitor

Acquire. Market share and US distribution arrive on day one, inside the hold of 4 years. Organic returns arrive late.

Rests on: Fact:€25m is available for one major investment. The fund expects an exit within 4 years.
Fact:The target brings market share and US distribution. Its valuation is high, customer concentration is material and it depends on its founder.
Fact:Management prefers organic investment. The board prefers the acquisition.
Assumes: A buyer at exit pays 9.0x for the acquired earnings as readily as for the core.
Consequence for finance: Test the exit case on retained earnings of €2.8m, not the reported figure.

Finance

Argues against: acquire the competitor

Do not acquire on these numbers. The headline multiple is 6.9x. On retained earnings it is 9.7x, and the deal is worth −€1.9m.

Rests on: Fact:The target brings market share and US distribution. Its valuation is high, customer concentration is material and it depends on its founder.
Assumption:The target earns €3.6m EBITDA and is priced at €25m, with €2m of integration cost. 45% of its revenue rests on the founder’s relationships. Its top 3 customers are 55% of revenue.
Assumption:Untested, 50% of founder-dependent revenue is assumed to leave with the founder. If transfer is demonstrated, 10%. If it is not transferable, 80%.
Assumes: 50% of founder-dependent revenue leaves with the founder.
Consequence for commercial: Customer-by-customer retention evidence would replace this assumption with a fact.

Commercial

Conditionally for: invest organically

Organic wins only if the two products have a reason to win. Today that is conviction, not evidence. Test it before committing.

Rests on: Fact:The organic plan is production modernisation, 2 new products and a US commercial team. Returns take longer and the market window may narrow.
Unknown:Whether there is unmet demand, and a durable reason the new products can win.
Assumes: The market window stays open for 3 years.
Consequence for finance: The organic case ranges from −€12.9m to €15.5m. Plan on neither.

Operations

Conditionally for: invest organically

Modernisation, two launches and a US team are three programmes on one management team. An acquisition would add integration as a fourth.

Rests on: Fact:The organic plan is production modernisation, 2 new products and a US commercial team. Returns take longer and the market window may narrow.
Unknown:Whether the organisation can execute the organic plan, and how quickly it reaches value.
Assumes: Current leaders can carry one major programme beyond running the business.
Consequence for governance: Whichever option is chosen, sequence it. The plan as written assumes attention that does not exist.

Conflict

The story against the value

Governance against Finance

The board’s equity story shows €7.4m. The same deal on retained earnings shows −€1.9m.

Calculated

Acquisition value, on retained earnings

−€1.9m

The equity story after the founder leaves.

Assumption: Assumption carrying weight

Untested, 50% of founder-dependent revenue is assumed to leave with the founder. If transfer is demonstrated, 10%. If it is not transferable, 80%.

Low confidence. If this is wrong, the calculations that rest on it move with it.

Unknown: Evidence to obtain first

Whether the target’s customer relationships transfer once the founder leaves.

The answer could be “relationships demonstrably transfer” or “relationships stay with the founder”. They lead to different decisions, which makes this the question to settle first.

Unknown: Evidence to obtain first

Whether there is unmet demand, and a durable reason the new products can win.

The answer could be “differentiation is evidenced” or “the segment is saturated”. They lead to different decisions, which makes this the question to settle first.

Authority gate

Transferability is not demonstrated

Commitment of capital and any acquisition go to the board or investment committee.

Human decision required

The critic

A separate pass reads the positions for conflict, unsupported certainty, benefits counted twice, omitted effects and false precision.

Contradiction between functionsGovernance, Finance
Governance and Finance take opposite sides on "Acquire the competitor". Both cannot be followed.
Unsupported certaintyGovernance
The equity story values the target at €7.4m of created value. It assumes every customer stays when the founder leaves. Nothing in evidence supports that.
Omitted second-order effectGovernance, Operations
Every option draws on the same leadership team. Nobody has counted management attention as a constraint.
False precisionCommercial, Finance
Organic value runs from −€12.9m to €15.5m. The midpoint of a range that wide is not an estimate.
Highest-value missing evidenceCommercial, Risk
Two unknowns can each change this decision: whether the target’s relationships transfer, and whether the products have market space. Transferability comes first. It prevents the most expensive mistake.

Where that leaves the room

Agreed

Nobody disputes that the target depends on its founder, or that the capital should create value a buyer will pay for.

Still in dispute

Governance and Finance. Whether the acquisition creates value. The board counts reported earnings. Finance counts what stays.

Not for analysis to decide

Commitment of capital and any acquisition belong to the board or investment committee. Analysis can normalise diligence, test valuation, model scenarios and name the evidence gaps.

The disagreements are kept. Someone accountable has to choose between them.

Decide

Options, trade-offs and an accountable call.

Three credible courses of action. Each one is carried by assumptions that would need to be true. Choose the one you would take. Your choice is not scored.

Acquire the competitorImmediate market share, US distribution and a changed equity story. For this to be right:

Customers stay when the founder leaves.
A buyer at exit values the acquired earnings like the core.
Management can integrate a business while running its own.

Invest organicallyModernise production, launch two products and build a US team. For this to be right:

There is market space, and a durable reason these products win.
The window stays open long enough to reach value inside the hold.
The organisation can run three programmes at once.

Reduce debt and waitStrengthen the balance sheet and keep the option to act later. For this to be right:

A better opportunity will appear inside the hold.
The fund will accept resilience as a use of capital.
Standing still does not cost market position.

Christianna’s judgement

Not the acquisition as it stands. Between the other two, the evidence decides.

Founder dependence has not been separated from company value, so the acquisition is not yet a responsible use of €25.0m. Organic investment against debt reduction turns on differentiation, which is untested. The next money spent is on evidence.

The decision as signed, at the starting position

Not the acquisition as it stands. Organic investment or debt reduction, decided by evidence.

Organic investment is justified only if there is credible evidence of market space and a defensible reason the products can win.

Innovation may come from product, business model, channel, experience, brand, pricing or cost structure. It need not be technological.

If the company would simply add undifferentiated capacity to a saturated market, I reduce debt and preserve optionality.

Rejected: Pursuing the acquisition before founder dependence has been separated from durable company value.
The assumption carrying it: That the value being bought sits in the company and not in its founder.
Authority I keep: Capital commitment and acquisition sit with the investment committee or board.
What I would delegate to AI: Normalising diligence, testing valuation assumptions, modelling scenarios and identifying evidence gaps.
What would change my mind: The acquisition becomes viable if the valuable relationships and capabilities are demonstrably transferable and the economics remain attractive after realistic retention and integration assumptions. Organic investment becomes viable when market differentiation and execution capability are evidenced.

Do not confuse pressure to deploy capital with evidence that capital should be deployed.

Christianna Hamilton

This is one accountable judgement for the stated objective and evidence. It is not offered as the universal answer.

Act

Bounded actions, owners and approvals.

A decision is finished when it has owners, limits and a way of being checked.

First action

Commission the evidence that decides it: customer-level transferability at the target, and market space for the two products.

Measure to watch

Exit-value sensitivity under each option, as the evidence arrives.

Establish whether customer relationships transfer after the founder leaves.
CommercialPrepare for approval
Assess the depth and independence of the acquired management team.
OperationsPrepare for approval
Test customer concentration and retention sensitivity.
RiskDraft
Find evidence of unmet demand or market whitespace.
CommercialPrepare for approval
Establish product differentiation and how long it is likely to last.
CommercialPrepare for approval
Assess organic execution capacity and time to value.
OperationsRecommend
Set out debt cost, covenant headroom and the value of resilience.
FinanceDraft
Model exit-value sensitivity under each option.
FinanceDraft

Where calculation ends and human authority begins

Calculate and surface. Evidence, assumptions, arithmetic and consequences are made visible.
Investigate and challenge. AI can extend the search, prepare options and test for conflict or unsupported certainty.
Decide and own. An accountable person weighs the trade-offs, makes the call and remains responsible for what follows.

Learn

What would show the judgement was wrong.

A judgement should say in advance what would overturn it. Change one material condition and see whether it holds.

The relationships transferDiligence shows customers contracted to the company, with key accounts run by second-tier management.The segment is saturatedMarket work finds no whitespace. The 2 new products would add undifferentiated capacity.The products have a reason to winPre-orders and channel commitments evidence demand for both new products.

Next decisionDistribution is positioningPremium consumer brand Previous decisionFunding the present without selling the futureLive-entertainment company

A decision of your own

If a situation in your organisation has this shape, I would be glad to talk it through.

hello@christiannahamilton.com

Method and provenance

The scenario is illustrative. It does not describe a client, an engagement or a real company.

What the tools do, and what remains human

Calculate and surface. Arithmetic and thresholds are handled consistently so the same inputs produce the same result.
Investigate and challenge. Functional positions expose disagreement. The critic looks for conflict, missing evidence, double counting and unsupported certainty. A live reading, where offered, can extend that challenge but cannot alter the underlying numbers or the signed decision.
Decide and own. The signed judgement is Christianna Hamilton’s. It is written in advance and remains the responsibility of a person, not a system.

Evidence

Items marked given in the scenario come from the written brief. Items marked illustrative modelling assumption are quantities added so that consequences can be calculated. Evidence last reviewed 2026-09-21.

Calculations in this decision

Quantity	Unit	What it assumes
Leverage	multiple	Net debt over EBITDA.
Covenant headroom	multiple	Covenant less current leverage.
Founder-dependent revenue lost	per cent	10% if transfer is demonstrated, 80% if not transferable, otherwise the untested assumption.
Target earnings at risk	EUR million	Earnings follow revenue proportionally.
Target earnings retained	EUR million	None beyond its inputs.
Headline price multiple	multiple	Price over reported EBITDA.
Effective price multiple	multiple	Price plus integration over retained EBITDA.
Acquisition value, as presented	EUR million	Every customer stays. No integration cost.
Acquisition value, on retained earnings	EUR million	Retained earnings at the exit multiple, less price and integration.
Organic value, if the products win	EUR million	Linear ramp to maturity. Reduced to the undifferentiated share if differentiation is absent.
Organic value, if they do not	EUR million	Undifferentiated capacity achieves only a share of the planned uplift.
Interest saved by paying down debt	EUR million	Simple interest over the hold.
Leverage after paydown	multiple	All capital applied to debt.
Days by which the deadline precedes the evidence	days	Diligence cannot be compressed.